Der Diabetologe

, Volume 9, Issue 2, pp 128–134 | Cite as

Schilddrüsenerkrankungen und Zöliakie

Früherkennung und Therapie bei pädiatrischen Typ-1-Diabetes-Patienten
Leitthema
  • 159 Downloads

Zusammenfassung

Bei Kindern und Jugendlichen mit Typ-1-Diabetes treten Autoimmunerkrankungen wie Zöliakie und Autoimmunthyreoiditis überproportional häufig auf. Gemeinsame exponierende oder auslösende Faktoren und auch genetische Determinanten werden für die Ätiopathogenese dieser Autoimmunerkrankungen diskutiert, sind bisher jedoch nicht ausreichend geklärt. In der Regel verlaufen diese Erkrankungen ohne eindeutige klinische Symptomatik, daher kann ihre Früherkennung nur durch regelmäßiges Screening der Patienten mit erhöhtem Risiko erfolgen. Dazu gehört die serologische Bestimmung der spezifischen Autoantikörper. Die Empfehlungen in den nationalen und internationalen Leitlinien dienen dem einheitlichen Vorgehen beim Screening und bei der Behandlungsindikation. Zu spät erkannte Begleiterkrankungen können zu klinisch relevanten Stoffwechselproblemen und weiteren vermeidbaren Komplikationen führen.

Schlüsselwörter

Typ-1-Diabetes Autoimmunthyreoiditis Antikörper Screening Leitlinien 

Thyroid disorders and celiac disease

Early recognition and treatment of pediatric patients with type 1 diabetes

Abstract

Celiac disease (CD) and autoimmune thyroiditis (AIT) occur more frequently in children and adolescents with type 1 diabetes than in the background population. Common pathogenetic mechanisms and genetic determinants are discussed; however, no clear explanations for their coincidence are available so far. Both diseases frequently present without apparent clinical symptoms; therefore, serological screening by autoantibody testing is required for early detection. The recommendations in national and international guidelines serve to provide a uniform and standardized screening procedure as well as the treatment of patients with clinically asymptomatic disorders and evidence of autoimmunity. Delay in the detection of associated diseases may lead to clinical relevant but otherwise preventable complications.

Keywords

Type1 diabetes mellitus Autoimmune thyroiditis Antibodies Screening Guidelines 

Notes

Interessenkonflikt

Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Amin R, Murphy N, Edge J et al (2002) A longitudinal study of the effect of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and coeliac disease. Diabetes Care 25:1117–1122PubMedCrossRefGoogle Scholar
  2. 2.
    Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) (2005) Clinical practice guidelines: type 1 diabetes in children and adolescents. http://www.nhmrc.gov.au/guidelines/publicationsGoogle Scholar
  3. 3.
    Barera G, Bonfanti R, Viscardi M et al (2002) Occurrence of celiac disease after onset of type 1 diabetes: a six-year prospective longitudinal study. Pediatrics 109:833–838PubMedCrossRefGoogle Scholar
  4. 4.
    Chase HP, Garg SK, Cockerham RS et al (1990) Thyroid hormone replacement and growth in children with subclinical hypothyroidism and diabetes. Diab Med 7:299–303CrossRefGoogle Scholar
  5. 5.
    Corrao G, Corazza GR, Bagnardi V et al (2001) Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358:356–361PubMedCrossRefGoogle Scholar
  6. 6.
    Cronin CC, Shanahan F (2003) Exploring the iceberg – the spectrum of celiac disease. Am J Gastroenterol 98:518-519PubMedGoogle Scholar
  7. 7.
    Dayan CM, Daniels HD (1996) Chronic autoimmune thyroiditis. N Engl J Med 335:99–107PubMedCrossRefGoogle Scholar
  8. 8.
    Dittmar M, Kahaly GJ (2003) Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metab 88:2983–2992PubMedCrossRefGoogle Scholar
  9. 9.
    Fröhlich-Reiterer EE, Hofer S, Kaspers S et al (2008) Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus – data from a German/Austrian multicentre survey. Pediatr Diabetes 9:546–553PubMedCrossRefGoogle Scholar
  10. 10.
    Gujral N, Freeman HJ, Thomson AB (2012) Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 18(42):6036–6059PubMedCrossRefGoogle Scholar
  11. 11.
    Hansen D, Brock-Jacobsen B, Lund E et al (2006) Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years‘ follow-up. Diabetes Care 29:2452–2456PubMedCrossRefGoogle Scholar
  12. 12.
    Hill ID, Dirks MH, Liptak GS et al (2005) Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 40:1–19PubMedCrossRefGoogle Scholar
  13. 13.
    Holl RW, Böhm B, Loos U et al (1999) Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type. Horm Res 52:113–118PubMedCrossRefGoogle Scholar
  14. 14.
    Holterhus PM, Beyer P, Bürger-Büsing J et al (2009) Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. Kirchheim, MainzGoogle Scholar
  15. 15.
    Husby S, Koletzko S, Korponay-Szabó IR et al (2012) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54:136–160PubMedCrossRefGoogle Scholar
  16. 16.
    Karell K, Louka AS, Moodie SJ et al (2003) HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 64:469–477PubMedCrossRefGoogle Scholar
  17. 17.
    Karges B, Muche R, Knerr I et al (2007) Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial. J Clin Endocrinol Metab 92:1647–1652PubMedCrossRefGoogle Scholar
  18. 18.
    Kaspers S, Kordonouri O, Schober E et al (2004) Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with celiac disease: a multicenter survey. J Pediatr 145:790–795PubMedCrossRefGoogle Scholar
  19. 19.
    Kordonouri O, Dieterich W, Schuppan D et al (2000) Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with type 1 diabetes mellitus. Diabet Med 17:441–444PubMedCrossRefGoogle Scholar
  20. 20.
    Kordonouri O, Klinghammer A, Lang EB et al (2002) Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus: a multicenter survey. Diabetes Care 25:1346–1350PubMedCrossRefGoogle Scholar
  21. 21.
    Kordonouri O, Hartmann R, Deiss D et al (2005) Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty. Arch Dis Child 90:411–414PubMedCrossRefGoogle Scholar
  22. 22.
    Kordonouri O, Maguire AM, Knip M et al (2009) Other complications and associated conditions with diabetes in children and adolescents. Pediatr Diabetes 10(Suppl 12):204–210PubMedCrossRefGoogle Scholar
  23. 23.
    Kordonouri O, Charpentier N, Hartmann R (2011) GADA positivity at onset of type 1 diabetes is a risk factor for the development of autoimmune thyroiditis. Pediatr Diabetes 12:31–33PubMedCrossRefGoogle Scholar
  24. 24.
    Lewis HM, Renaula TL, Garioch JJ et al (1996) Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 135:363–367PubMedCrossRefGoogle Scholar
  25. 25.
    Lewis NR, Logan RF, Hubbard RB, West J (2008) No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 27:1140–1147PubMedCrossRefGoogle Scholar
  26. 26.
    Lorini R, d’Annunzio G, Vitali L et al (1996) IDDM and autoimmune thyroid disease in pediatric age group. J Pediatr Endocrinol Metab 9(Suppl 1):89–94PubMedGoogle Scholar
  27. 27.
    Marsh MN (1992) Gluten, major histocompatibility complex, and the small intestine. A molecular and immunologic approach to the spectrum of gluten sensitivity („celiac sprue“). Gastroenterology 102:330–354PubMedGoogle Scholar
  28. 28.
    Mohn A, Cerruto M, Lafusco D et al (2001) Celiac disease in children and adolescents with type 1 diabetes: importance of hypoglycemia. J Pediatr Gastroenterol Nutr 32:37–40PubMedCrossRefGoogle Scholar
  29. 29.
    Mohn A, Di Michele S, Di Luzio R et al (2002) The effect of subclinical hypothyroidism on metabolic control in children and adolescents with type 1 diabetes mellitus. Diabet Med 19:70–73PubMedCrossRefGoogle Scholar
  30. 30.
    Mollazadegan K, Kugelberg M, Montgomery SM et al (2012) A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease. Diabetes Care 36:316–321PubMedCrossRefGoogle Scholar
  31. 31.
    Not T, Tommasini A, Tonini G et al (2001) Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with type 1 diabetes mellitus. Diabetologia 44:151–155PubMedCrossRefGoogle Scholar
  32. 32.
    O’Connor TM, Cronin CC, Loane JF et al (1999) Type 1 diabetes mellitus, coeliac disease, and lymphoma: a report of four cases. Diabet Med 16:614–617Google Scholar
  33. 33.
    Pham-Short A, Donaghue KC, Ambler G et al (2012) Coeliac disease in type 1 diabetes from 1990 to 2009: higher incidence in young children after longer diabetes duration. Diabet Med 29:e286–e289PubMedCrossRefGoogle Scholar
  34. 34.
    Saukkonen T, Vaisanen S, Akerblom HK, Savilahti E (2002) Coeliac disease in children and adolescents with type 1 diabetes: a study of growth, glycaemic control, and experiences of families. Acta Paediatr 91:297–302PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Diabetes-Zentrum für Kinder und Jugendliche, Kinder- und Jugendkrankenhaus AUF DER BULTHannoverDeutschland

Personalised recommendations